Simultaneous Therapy with Intravitreal Dexamethasone Implant and Bevacizumab for the Treatment of Macular Edema.

about

Simultaneous Therapy with Intravitreal Dexamethasone Implant and Bevacizumab for the Treatment of Macular Edema.

Item

http://www.wikidata.org/entity/Q41809125

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Simultaneous Therapy with Intr ...... he Treatment of Macular Edema.

@en

type

Item

label

Simultaneous Therapy with Intr ...... he Treatment of Macular Edema.

@en

prefLabel

Simultaneous Therapy with Intr ...... he Treatment of Macular Edema.

@en

P1476

Simultaneous Therapy with Intr ...... he Treatment of Macular Edema.

@en

P2093

André Maia

http://www.w3.org/2001/XMLSchema#string

Felipe L de Andrade

http://www.w3.org/2001/XMLSchema#string

Flavio S Lopes

http://www.w3.org/2001/XMLSchema#string

Gabriel C de Andrade

http://www.w3.org/2001/XMLSchema#string

Tiago S Prata

http://www.w3.org/2001/XMLSchema#string

P2860

Perspective on the role of Ozurdex (dexamethasone intravitreal implant) in the management of diabetic macular oedema

Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials.

Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results.

Dexamethasone intravitreal implant in combination with laser photocoagulation for the treatment of diffuse diabetic macular edema.

Intravitreal combination of dexamethasone sodium phosphate and bevacizumab in the treatment of exudative AMD.

Optimal Treatment of Retinal Vein Occlusion: Canadian Expert Consensus.

Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study.

Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema.

Dexamethasone intravitreous implant versus bevacizumab for central retinal vein occlusion-related macular oedema: a prospective randomized comparison.

Asymmetry of diurnal intraocular pressure fluctuation between right and left eyes.

P304

4-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28289686

http://www.w3.org/2001/XMLSchema#string

P921

bevacizumab

dexamethasone

P932

5342876

http://www.w3.org/2001/XMLSchema#string